MX9709646A - Derivados de bencimidazol como inhibidores de proliferacion de celulas de musculo liso. - Google Patents
Derivados de bencimidazol como inhibidores de proliferacion de celulas de musculo liso.Info
- Publication number
- MX9709646A MX9709646A MX9709646A MX9709646A MX9709646A MX 9709646 A MX9709646 A MX 9709646A MX 9709646 A MX9709646 A MX 9709646A MX 9709646 A MX9709646 A MX 9709646A MX 9709646 A MX9709646 A MX 9709646A
- Authority
- MX
- Mexico
- Prior art keywords
- inhibitors
- cell proliferation
- smooth muscle
- muscle cell
- benzimidazole derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/12—Radicals substituted by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/08—Radicals containing only hydrogen and carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
En la presente se describen compuestos y sales farmacéuticamente aceptables de compuestos de formula (I) o (II), en las qur R es alquilo, fenilo o fenilo sustituido; R2 es hidrogeno, hologeno, alcoxi o alquilo; R1 es hidrogeno, alquilo, arilo, arilalquilo o bencilo sustituido; los cuales son utiles como inhibidores de proliferacion de células de musculo liso.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/468,482 US6288100B1 (en) | 1995-06-06 | 1995-06-06 | Benzimidazole derivatives |
US08468482 | 1995-06-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
MX9709646A true MX9709646A (es) | 1998-07-31 |
MXPA97009646A MXPA97009646A (es) | 1998-11-09 |
Family
ID=
Also Published As
Publication number | Publication date |
---|---|
IL118384A0 (en) | 1996-09-12 |
AR002748A1 (es) | 1998-04-29 |
US6288100B1 (en) | 2001-09-11 |
AU5967396A (en) | 1996-12-24 |
JPH11506749A (ja) | 1999-06-15 |
ZA964692B (en) | 1997-12-05 |
BR9609365A (pt) | 1999-05-18 |
NZ309490A (en) | 1999-09-29 |
AU713043B2 (en) | 1999-11-25 |
WO1996039390A1 (en) | 1996-12-12 |
KR19990022372A (ko) | 1999-03-25 |
CA2223393A1 (en) | 1996-12-12 |
EP0830343A1 (en) | 1998-03-25 |
CN1192205A (zh) | 1998-09-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20013369L (no) | Arylpiperazinyl-cykloheksyl-indol-derivater for behandling av depresjon | |
HUP9904361A2 (hu) | Izobutil-gaba és származékai alkalmazása fájdalom kezelésére | |
IL146851A0 (en) | 1- (4-sulfamylaryl)- 3- substituted -5-ayl-2-pyrazolines as inhibitors of cyclooxygenase-2 | |
MY119150A (en) | Azetidine derivatives, their preparation and medicaments containing them | |
MX9800718A (es) | Derivados de 2-(4-substituidos)-bencilamino-2-metil- propanamida. | |
ES538418A0 (es) | Un derivado de indol-3-carboxamida | |
PT918776E (pt) | Sintese total de acilfulvenos antitumorais | |
MX9806171A (es) | Derivados 2,3-benzodiazepina y sus usos como inhibidores del receptor-ampa. | |
LU92263I2 (fr) | Imépitoïne et ses dérivés pharmaceutiquement acceptables (PEXION) | |
NZ332012A (en) | 4-[(thien-3-yl)methyl] imidazole derivatives having alpha-2-adrenoceptor agonistic activity | |
HUP0302961A2 (hu) | (Aminoalkoxibenzoil) benzofuránok vagy benzotiofének, eljárás ilyen vegyületek előállítására és ilyen vegyületeket tartalmazó készítmények | |
ES2125161A1 (es) | Nuevos derivados de 2-(3h)-oxazolona. | |
ATE262509T1 (de) | Indolinderivate als lichtschutzmittel | |
AU3749495A (en) | Diazepino-indoles as phosphodiesterase iv inhibitors | |
HUP9900679A2 (hu) | Simaizom sejtburjánzást gátló benzimidazolszármazékok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
AP2001002045A0 (en) | FKBP inhibitors. | |
MX9709646A (es) | Derivados de bencimidazol como inhibidores de proliferacion de celulas de musculo liso. | |
DE69824722D1 (de) | Benzimidazole derivate | |
MX9709465A (es) | Derivados de bencimidazol 2-sustituidos como inhibidores de la proliferacion de celulas del musculo liso. | |
NO934227L (no) | Pyrrolderivater, fremgangsmåte for deres fremstilling og terapeutiske anvendelse | |
DE60002292D1 (de) | (3,4-dihydro-2h-benzo[1,4]oxazinyl-methyl)-3-(1h-indol-3-yl)-alkylamine | |
ES479110A1 (es) | Procedimiento para preparar derivados de benzamidina. | |
ES2103675A1 (es) | Nuevas piperidinas sustituidas. | |
NZ335975A (en) | Heterocyclic substituted pyrrolidine amide derivatives useful in treating respiratory diseases | |
AU2003261245A1 (en) | Benzyl morpholine derivatives |